Original language | Undefined/Unknown |
---|---|
Journal | Journal of Clinical Oncology |
DOIs | |
Publication status | Published - 2021 |
The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)
Arndt Vogel, Thorsten Oliver Goetze, Guido Hausner, Michael Geissler, Gabriele Margareta Siegler, Ludwig Fischer von Weikersthal, Angelika M. R. Kestler, Matthias Kleiss, Tobias Mueller, Andreas Teufel, Jens Marquardt, Maria A. Gonzalez-Carmona, Daniel Wilhelm Mueller, Regina Eickhoff, Enrico N. de Toni, Oliver Waidmann, Salah-Eddin Al-Batran
Research output: Contribution to journal › Original Article › peer-review
3
Citations
(Web of Science)